Welcome From The Conference Secretariat
Dear Colleagues,
The Research Catalyst is privileged to organize Cancer Science and Oncology Research eConference (CancerSciRes-eCon2023 (Edition1)) to be held during May 29, 2023 (London GMT+1) and May 30, 2023 (Tokyo GMT+ 9) Online. The conference aims at sharing new ideas, possibilities, and the latest technological advances among students, professionals, researchers, scientists, and industrialists in the field of Cancer research for providing better solutions to everyday challenges.
CancerSciRes-eCon2023 (Edition1) provides an advanced online forum for research on Cancers . The online conference is expected to foster oral presentations and private lounge meetings for networking among participants. The conference aims to encourage scientists to present their experimental and theoretical results in as much detail as possible through their presentations.
The theme of the conference focuses on recent innovations and research works on Cancers and includes sessions and interactive discussions.
The conference will discuss how Cancers research helps in progress and applications in various fields of science. Major breakthroughs in these fields to raise the bar in the scientific field will be the major goal of discussions and sessions of the conference. The conference encourages the exchange of ideas and knowledge across multiple disciplines of Cancers research and includes plenary, keynote lectures, and video presentations.
We look forward to seeing you at CancerSciRes-eCon2023 (Edition1)
Regards,
Kris G
Conference Secretary
The Research Catalyst
Axel H. Schönthal
University of Southern California, USA
Axel H. Schönthal
University of Southern California, USA
Mara H. O’Brien
University of Connecticut Health Center, USA
Adele Vivacqua
University of Calabria, Italy
Keaton Funderburk
New York University Shanghai, China
Fatma Alshuhoumi
Sultan Qaboos University, Oman
Registration
The registration fee includes access to all conference sessions, a conference participation certificate, and an abstract book (pdf).
Participation to the conference is considered final only once the registration fees have been paid. The number of participants is limited: once the number of paid registrations reaches the maximum number of participants, unpaid registrations will be canceled.
Certificate of Attendance: Upon request, the participants of the event will receive an electronic Certificate of Attendance by email once the event is concluded.
Members of partnering societies will receive a 20% discount on the registration fees. For special discount and group discount requests contact the conference secretariat at: theresearchcatalyst.com/contact
- Cancer genomics and personalized medicine
- Cancer immunotherapy and immune-oncology
- Cancer metabolism and metabolic reprogramming
- Oncology nursing and supportive care
- Cancer epidemiology and cancer prevention
- Tumor microenvironment and cancer cell signaling
- Clinical trials and translational research in oncology
- Radiation therapy and radiobiology
- Cancer stem cells and cancer cell heterogeneity
- Pediatric oncology and rare cancers
- Cancer diagnosis and early detection
- Palliative care and end-of-life issues in oncology
- Surgical oncology and minimally invasive procedures
- Oncology pathology and cancer biomarkers
- Cancer survivorship and quality of life after treatment
DAY-1
29 MAY 2023
(LONDON GMT+1)
9:00 AM
TBA
By Sadik Bhattarai
Jeonbuk National University, South Korea
9:25 AM
TBA
By Dr. Vaishali M. Patil,
KIET Group of Institutions, India
9:50 AM
In Silico Computation Method for ACP Classification and AntiCancer Peptide class Validation Servers in Cancer Research
By Dileep Kumar
Teresian research institute, India
10:15 AM
TBA
By Umar Shoib
University of Gujrat, Pakistan
10:40 AM
The Promises of Radiomics for Medical Research and its
Implementation Framework
By Fatma Alshuhoumi
Sultan Qaboos University, Oman
11:05 AM
TBA
By Ahmad Reza Farmani
Fasa University Of Medical Sciences, Iran
11:30 AM
17β-estradiol modulates the expression of miRNAs in breast cancer cells and in tumor
microenvironment
By Adele Vivacqua
University of Calabria, Italy
BREAK 11:55 ----------------------------- 3:00 PM
3:00 PM
Estrogen Receptor Alpha Protects Against Hepatocarcinogenesis in Female Mice
By Mara H. O’Brien
University of Connecticut Health Center, USA
3:25 PM
Steroid utility, immunotherapy, and brain tumor management: an update on conflicting therapies
By Lucke Wold Brandon
University of Florida, USA
3:50 PM
TBA
By Yu-Wei Tim Cheng
Cleveland Clinic, USA
4:15 PM
Perillyl Alcohol (NEO100), a Monoterpene with Multifaceted Biological Activities
By Axel H. Schönthal
University of Southern California, USA
